Literature DB >> 6239719

Human pregnancy serum inhibits interleukin-2 production.

N S Nicholas, G S Panayi, A M Nouri.   

Abstract

Cell-mediated immunity may be depressed during pregnancy. We used the two way mixed lymphocyte reaction as an in vitro model of cell mediated immunity and studied the effect of pregnancy sera on this system by the amount of tritiated thymidine taken up by activated lymphocytes. We found that: (1) pregnancy sera contain a factor inhibiting the mixed lymphocyte reaction; (2) the inhibition of the mixed lymphocyte reaction induced by sera could be reversed by the addition of the supernatant from allogeneic mixed lymphocyte reaction; (3) pure interleukin-1 could not reverse the inhibitory effect and (4) recombinant interleukin-2 (IL-2) completely reversed the inhibitory effect of pregnancy sera on the mixed lymphocyte reaction. We conclude that a factor (or factors) present in serum from pregnant women is capable of inhibiting the generation of IL-2 during lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6239719      PMCID: PMC1577087     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Changes in lymphocyte function during pregnancy.

Authors:  O M Petrucco; R F Seamark; K Holmes; I J Forbes; R G Symons
Journal:  Br J Obstet Gynaecol       Date:  1976-03

2.  Response to mitogen during pregnancy and the postpartum period.

Authors:  P K Poskitt; E A Kurt; B B Paul; R J Selvaraj; A J Sbarra; G W Mitchell
Journal:  Obstet Gynecol       Date:  1977-09       Impact factor: 7.661

3.  Cell-mediated immunity in pregnant patients with and without a previous history of spontaneous abortions.

Authors:  G Garewal; S Sehgal; B K Aikat; A N Gupta
Journal:  Br J Obstet Gynaecol       Date:  1978-03

4.  Distribution of MHC antigens in human placental chorionic villi.

Authors:  W P Faulk; A R Sanderson; A Temple
Journal:  Transplant Proc       Date:  1977-06       Impact factor: 1.066

5.  The mechanism of initiation of parturition in the ewe.

Authors:  G C Liggins; R J Fairclough; S A Grieves; J Z Kendall; B S Knox
Journal:  Recent Prog Horm Res       Date:  1973

6.  Is cortisol responsible for inhibition of MLC reactions by pregnancy plasma?

Authors:  S Kasakura
Journal:  Nature       Date:  1973 Dec 21-28       Impact factor: 49.962

7.  Identification of an immunosuppressive factor in pregnancy serum.

Authors:  W H Stimson; J C Blackstock
Journal:  Obstet Gynecol       Date:  1976-09       Impact factor: 7.661

8.  Distribution of beta2 microglobulin and HLA in chorionic villi of human placentae.

Authors:  W P Faulk; A Temple
Journal:  Nature       Date:  1976-08-26       Impact factor: 49.962

9.  Cell-mediated immunity in pregnant women.

Authors:  Y Tomoda; M Fuma; T Miwa; N Saiki; N Ishizuka
Journal:  Gynecol Invest       Date:  1976

10.  Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions.

Authors:  R E Rocklin; J L Kitzmiller; C B Carpenter; M R Garovoy; J R David
Journal:  N Engl J Med       Date:  1976-11-25       Impact factor: 91.245

View more
  11 in total

1.  Postpartum autologous plasma transfusion: effect on RA.

Authors:  C D Scoville
Journal:  Ann Rheum Dis       Date:  1992-12       Impact factor: 19.103

2.  Placental isoferritin as a physiological downregulator of cellular immunoreactivity during pregnancy.

Authors:  L Sirota; B Kupfer; C Moroz
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

3.  Inhibition of pregnancy viability in mice following IL-2 administration.

Authors:  B U Tezabwala; P M Johnson; R C Rees
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

4.  Placental protein 14 (PP14) inhibits the synthesis of interleukin-2 and the release of soluble interleukin-2 receptors from phytohaemagglutinin-stimulated lymphocytes.

Authors:  A G Pockley; A E Bolton
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

5.  Pregnancy and immunity.

Authors:  S Lee
Journal:  BMJ       Date:  1994-07-09

6.  Tumor necrosis factor and pregnancy--a contribution to the immunology of reproduction.

Authors:  H J Voigt; L Steib
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

7.  Decreased interleukin 2 inhibitor in sera of patients with autoimmune disorders.

Authors:  J Y Djeu; T Kasahara; J E Balow; G C Tsokos
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

8.  Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease.

Authors:  Madhan Masilamani; Narendiran Rajasekaran; Anjana Singh; Hui-Zhi Low; Kerstin Albus; Swantje Anders; Frank Behne; Peter Eiermann; Katharina König; Clarissa Mindnich; Teodora Ribarska; Harald Illges
Journal:  Rheumatol Int       Date:  2008-05-24       Impact factor: 2.631

9.  Production of interleukin-1 by mononuclear cells of newborns and their mothers.

Authors:  H Bessler; L Sirota; F Dulitzky; M Djaldetti
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

10.  Suppression of lymphocyte activation and functions by a leukemia cell-derived inhibitor.

Authors:  J W Chiao; M Heil; Z Arlin; J D Lutton; Y S Choi; K Leung
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.